LINCS Extended Metadata Standard: Small molecules
Abbreviation: LINCS 2: Small molecules
This record replaces or incorporates the following deprecated resources:
Homepage http://www.lincsproject.org/LINCS/data/standards
Countries that developed this resource United States
Created in 2015
Taxonomic range
Knowledge Domains
Subjects
How to cite this record FAIRsharing.org: LINCS 2: Small molecules; LINCS Extended Metadata Standard: Small molecules; DOI: https://doi.org/10.25504/FAIRsharing.7rfpgs; Last edited: Jan. 8, 2019, 1:40 p.m.; Last accessed: Jan 26 2021 2:38 a.m.
Record added: April 27, 2016, 2:15 p.m.
Record updated:
March 30, 2017, 1:08 a.m. by cchung.
online documentation | http://www.lincsproject.org/LINCS/files/ ... |
Additional Information
Contact | sherry.jenkins@mssm.edu |
No XSD schemas defined
Conditions of Use
Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High-Throughput Screening Data from the Library of Integrated Network-based Cellular Signatures (LINCS).
Vempati UD,Chung C,Mader C,Koleti A,Datar N,Vidovic D,Wrobel D,Erickson S,Muhlich JL,Berriz G,Benes CH,Subramanian A,Pillai A,Shamu CE,Schurer SC
J Biomol Screen 2014
Reporting Guidelines
- LINCS Extended Metadata Standard: Induced Pluripotent Stem Cells
- LINCS Extended Metadata Standard: Differentiated Cells
- LINCS Extended Metadata Standard: Primary Cells
- LINCS Extended Metadata Standard: Embryonic Stem Cells
- LINCS Extended Metadata Standard: Proteins
- LINCS Extended Metadata Standard: Other Reagents
- LINCS Extended Metadata Standard: Antibody Reagents
- LINCS Extended Metadata Standard: Cell lines
- Minimum Information About a Bioactive Entity
- LINCS Extended Metadata Standard: Nucleic Acid Reagents
Terminology Artifacts
No semantic standards defined
Models and Formats
No syntax standards defined
Identifier Schemas
No identifier schema standards defined
Metrics
No metrics standards defined
The LINCS Data Portal provides a unified interface for searching LINCS dataset packages and reagents. LINCS data are being made openly available as a community resource through a series of data releases, so as to enable scientists to address a broad range of basic research questions and to facilitate the identification of biological targets for new disease therapies. LINCS datasets consist of assay results from cultured and primary human cells treated with bioactive small molecules, ligands such as growth factors and cytokines, or genetic perturbations. Many different assays are used to monitor cell responses, including assays measuring transcript and protein expression; cell phenotype data are captured by biochemical and imaging readouts. Assays are typically carried out on multiple cell types, and at multiple timepoints; perturbagen activity is monitored at multiple doses.
This record is not implemented by any policy.
Record Maintainer
Funds
NIH Common Fund, USA (Government body)
National Institutes of Health (NIH), Bethesda, MD, USA (Government body)